trans-Fatty acids facilitate DNA damage-induced apoptosis through the mitochondrial JNK-Sab-ROS positive feedback loop.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 02 2020
Historique:
received: 15 07 2019
accepted: 29 01 2020
entrez: 19 2 2020
pubmed: 19 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

trans-Fatty acids (TFAs) are unsaturated fatty acids that contain one or more carbon-carbon double bonds in trans configuration. Epidemiological evidence has linked TFA consumption with various disorders, including cardiovascular diseases. However, the underlying pathological mechanisms are largely unknown. Here, we show a novel toxic mechanism of TFAs triggered by DNA damage. We found that elaidic acid (EA) and linoelaidic acid, major TFAs produced during industrial food manufacturing (so-called as industrial TFAs), but not their corresponding cis isomers, facilitated apoptosis induced by doxorubicin. Consistently, EA enhanced UV-induced embryonic lethality in C. elegans worms. The pro-apoptotic action of EA was blocked by knocking down Sab, a c-Jun N-terminal kinase (JNK)-interacting protein localizing at mitochondrial outer membrane, which mediates mutual amplification of mitochondrial reactive oxygen species (ROS) generation and JNK activation. EA enhanced doxorubicin-induced mitochondrial ROS generation and JNK activation, both of which were suppressed by Sab knockdown and pharmacological inhibition of either mitochondrial ROS generation, JNK, or Src-homology 2 domain-containing protein tyrosine phosphatase 1 (SHP1) as a Sab-associated protein. These results demonstrate that in response to DNA damage, TFAs drive the mitochondrial JNK-Sab-ROS positive feedback loop and ultimately apoptosis, which may provide insight into the common pathogenetic mechanisms of diverse TFA-related disorders.

Identifiants

pubmed: 32066809
doi: 10.1038/s41598-020-59636-6
pii: 10.1038/s41598-020-59636-6
pmc: PMC7026443
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Caenorhabditis elegans Proteins 0
Guanine Nucleotide Exchange Factors 0
Oleic Acids 0
REI-1 protein, C elegans 0
RNA, Small Interfering 0
Reactive Oxygen Species 0
SH3BP5 protein, human 0
elaidic acid 4837010H8C
Doxorubicin 80168379AG
Linoleic Acid 9KJL21T0QJ
JNK Mitogen-Activated Protein Kinases EC 2.7.11.24
Protein Tyrosine Phosphatase, Non-Receptor Type 6 EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2743

Références

Gebauer, S. K., Psota, T. L. & Kris-Etherton, P. M. The diversity of health effects of individual trans fatty acid isomers. Lipids 42, 787–799, https://doi.org/10.1007/s11745-007-3095-8 (2007).
doi: 10.1007/s11745-007-3095-8 pubmed: 17694343
Estadella, D. et al. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm. 2013, 137579, https://doi.org/10.1155/2013/137579 (2013).
doi: 10.1155/2013/137579 pubmed: 23509418 pmcid: 3572653
Mensink, R. P., Zock, P. L., Kester, A. D. & Katan, M. B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146–1155 (2003).
doi: 10.1093/ajcn/77.5.1146
Morris, M. C. et al. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60, 194–200 (2003).
doi: 10.1001/archneur.60.2.194
Micha, R. & Mozaffarian, D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 5, 335–344, https://doi.org/10.1038/nrendo.2009.79 (2009).
doi: 10.1038/nrendo.2009.79 pubmed: 19399016
Lopez-Garcia, E. et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 135, 562–566 (2005).
doi: 10.1093/jn/135.3.562
Iwata, N. G. et al. Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PLoS One 6, e29600, https://doi.org/10.1371/journal.pone.0029600 (2011).
doi: 10.1371/journal.pone.0029600 pubmed: 22216328 pmcid: 3247279
Machado, R. M. et al. Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to trans fatty acids. Atherosclerosis 224, 66–74, https://doi.org/10.1016/j.atherosclerosis.2012.06.059 (2012).
doi: 10.1016/j.atherosclerosis.2012.06.059 pubmed: 22809447
Bassett, C. M. et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metab. 58, 1802–1808, https://doi.org/10.1016/j.metabol.2009.06.010 (2009).
doi: 10.1016/j.metabol.2009.06.010
Siddiqui, R. A., Harvey, K. A., Ruzmetov, N., Miller, S. J. & Zaloga, G. P. n-3 fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death. Br. J. Nutr. 102, 1811–1819, https://doi.org/10.1017/S0007114509992030 (2009).
doi: 10.1017/S0007114509992030 pubmed: 19822033
Hirata, Y. et al. trans-Fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway. J. Biol. Chem. 292, 8174–8185, https://doi.org/10.1074/jbc.M116.771519 (2017).
doi: 10.1074/jbc.M116.771519 pubmed: 28360100 pmcid: 5437226
Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36–46, https://doi.org/10.1038/nri2675 (2010).
doi: 10.1038/nri2675 pubmed: 19960040
Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721, https://doi.org/10.1038/nri3520 (2013).
doi: 10.1038/nri3520 pubmed: 23995626 pmcid: 4357520
Noguchi, T. et al. Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 283, 7657–7665, https://doi.org/10.1074/jbc.M708402200 (2008).
doi: 10.1074/jbc.M708402200 pubmed: 18211888
Roos, W. P., Thomas, A. D. & Kaina, B. DNA damage and the balance between survival and death in cancer biology. Nat. Rev. Cancer 16, 20–33, https://doi.org/10.1038/nrc.2015.2 (2016).
doi: 10.1038/nrc.2015.2 pubmed: 26678314
Roos, W. P. & Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 12, 440–450, https://doi.org/10.1016/j.molmed.2006.07.007 (2006).
doi: 10.1016/j.molmed.2006.07.007 pubmed: 16899408
Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nat. 461, 1071–1078, https://doi.org/10.1038/nature08467 (2009).
doi: 10.1038/nature08467
Montecucco, A., Zanetta, F. & Biamonti, G. Molecular mechanisms of etoposide. EXCLI J. 14, 95–108, https://doi.org/10.17179/excli2015-561 (2015).
doi: 10.17179/excli2015-561 pubmed: 26600742 pmcid: 4652635
Roos, W. P. & Kaina, B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 332, 237–248, https://doi.org/10.1016/j.canlet.2012.01.007 (2013).
doi: 10.1016/j.canlet.2012.01.007 pubmed: 22261329
Biton, S. & Ashkenazi, A. NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-alpha Feedforward Signaling. Cell 145, 92–103, https://doi.org/10.1016/j.cell.2011.02.023 (2011).
doi: 10.1016/j.cell.2011.02.023 pubmed: 21458669
Yao, Y. W. et al. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway. Biochem. Bioph Res. Co. 493, 1288–1295, https://doi.org/10.1016/j.bbrc.2017.09.153 (2017).
doi: 10.1016/j.bbrc.2017.09.153
Steelman, L. S. et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3, 192–222, https://doi.org/10.18632/aging.100296 (2011).
doi: 10.18632/aging.100296 pubmed: 21422497 pmcid: 3091517
Lambeth, J. D. Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunology 4, 181–189, https://doi.org/10.1038/nri1312 (2004).
doi: 10.1038/nri1312 pubmed: 15039755
Chambers, J. W. & LoGrasso, P. V. Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation. Journal of Biological Chemistry 286, https://doi.org/10.1074/jbc.M111.223602 (2011).
doi: 10.1074/jbc.M111.223602
Win, S. et al. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology 67, 2013–2024, https://doi.org/10.1002/hep.29689 (2018).
doi: 10.1002/hep.29689 pubmed: 29194686 pmcid: 5906137
Chambers, T. P., Portalatin, G. M., Paudel, I., Robbins, C. J. & Chambers, J. W. Sub-chronic administration of LY294002 sensitizes cervical cancer cells to chemotherapy by enhancing mitochondrial JNK signaling. Biochem. Bioph Res. Co. 463, 538–544, https://doi.org/10.1016/j.bbrc.2015.05.075 (2015).
doi: 10.1016/j.bbrc.2015.05.075
Win, S. et al. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. J. Hepatol. 62, 1367–1374, https://doi.org/10.1016/j.jhep.2015.01.032 (2015).
doi: 10.1016/j.jhep.2015.01.032 pubmed: 25666017 pmcid: 4439305
Salvi, M., Brunati, A. M. & Toninello, A. Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signaling. Free. Radic. Biol. Med. 38, 1267–1277, https://doi.org/10.1016/j.freeradbiomed.2005.02.006 (2005).
doi: 10.1016/j.freeradbiomed.2005.02.006 pubmed: 15855046
Hebert-Chatelain, E. Src kinases are important regulators of mitochondrial functions. Int. J. Biochem. Cell Biol. 45, 90–98, https://doi.org/10.1016/j.biocel.2012.08.014 (2013).
doi: 10.1016/j.biocel.2012.08.014 pubmed: 22951354
Miyazaki, T., Neff, L., Tanaka, S., Horne, W. C. & Baron, R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 160, 709–718, https://doi.org/10.1083/jcb.200209098 (2003).
doi: 10.1083/jcb.200209098 pubmed: 12615910 pmcid: 2173369
Ogura, M., Yamaki, J., Homma, M. K. & Homma, Y. Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components. Biochem. J. 447, 281–289, https://doi.org/10.1042/BJ20120509 (2012).
doi: 10.1042/BJ20120509 pubmed: 22823520 pmcid: 3459221
Ostman, A., Hellberg, C. & Bohmer, F. D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6, 307–320, https://doi.org/10.1038/nrc1837 (2006).
doi: 10.1038/nrc1837 pubmed: 16557282
Yan, Y. et al. 1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis. J. Immunother. Cancer 6, 148, https://doi.org/10.1186/s40425-018-0466-z (2018).
doi: 10.1186/s40425-018-0466-z pubmed: 30545412 pmcid: 6291986
Win, S., Than, T. A., Min, R. W. M., Aghajan, M. & Kaplowitz, N. c-Jun N-Terminal Kinase Mediates Mouse Liver Injury Through a Novel Sab (SH3BP5)-Dependent Pathway Leading to Inactivation of Intramitochondrial Src. Hepatology 63, 1987–2003, https://doi.org/10.1002/hep.28486 (2016).
doi: 10.1002/hep.28486 pubmed: 26845758 pmcid: 4874901
Frank, C. et al. Effective dephosphorylation of Src substrates by SHP-1. J. Biol. Chem. 279, 11375–11383, https://doi.org/10.1074/jbc.M309096200 (2004).
doi: 10.1074/jbc.M309096200 pubmed: 14699166
Chen, L. et al. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70, 562–570, https://doi.org/10.1124/mol.106.025536 (2006).
doi: 10.1124/mol.106.025536 pubmed: 16717135
Craig, A. L., Moser, S. C., Bailly, A. P. & Gartner, A. Methods for studying the DNA damage response in the Caenorhabdatis elegans germ line. Methods Cell Biol. 107, 321–352, https://doi.org/10.1016/B978-0-12-394620-1.00011-4 (2012).
doi: 10.1016/B978-0-12-394620-1.00011-4 pubmed: 22226529
Lee, H. C. et al. Caenorhabditis elegans mboa-7, a member of the MBOAT family, is required for selective incorporation of polyunsaturated fatty acids into phosphatidylinositol. Mol. Biol. Cell 19, 1174–1184, https://doi.org/10.1091/mbc.e07-09-0893 (2008).
doi: 10.1091/mbc.e07-09-0893 pubmed: 18094042 pmcid: 2262980
Tabara, H., Grishok, A. & Mello, C. C. RNAi in C. elegans: soaking in the genome sequence. Sci. 282, 430–431, https://doi.org/10.1126/science.282.5388.430 (1998).
doi: 10.1126/science.282.5388.430
Kennedy, S., Wang, D. & Ruvkun, G. A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nat. 427, 645–649, https://doi.org/10.1038/nature02302 (2004).
doi: 10.1038/nature02302
Mori, K. et al. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan. Circ. J. 79, 2017–2025, https://doi.org/10.1253/circj.CJ-14-0750 (2015).
doi: 10.1253/circj.CJ-14-0750 pubmed: 26166015
Dawczynski, C. & Lorkowski, S. Trans-fatty acids and cardiovascular risk: does origin matter? Expert. Rev. Cardiovas 14, 1001–1005, https://doi.org/10.1080/14779072.2016.1199956 (2016).
doi: 10.1080/14779072.2016.1199956
Yang, Q. H. et al. Plasma trans-Fatty Acid Concentrations Continue to Be Associated with Serum Lipid and Lipoprotein Concentrations among US Adults after Reductions in trans-Fatty Acid Intake. J. Nutr. 147, 896–907, https://doi.org/10.3945/jn.116.245597 (2017).
doi: 10.3945/jn.116.245597 pubmed: 28381527
Dorfman, S. E. et al. Metabolic implications of dietary trans-fatty acids. Obes. 17, 1200–1207, https://doi.org/10.1038/oby.2008.662 (2009).
doi: 10.1038/oby.2008.662
Hussein, O. et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 13, 361–368 (2007).
doi: 10.3748/wjg.v13.i3.361
Liu, W. H., Lin, C. C., Wang, Z. H., Mong, M. C. & Yin, M. C. Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice. J. Agric. Food Chem. 58, 10247–10252, https://doi.org/10.1021/jf102379n (2010).
doi: 10.1021/jf102379n pubmed: 20799701
Kozlov, A. V., Lancaster, J. R. Jr., Meszaros, A. T. & Weidinger, A. Mitochondria-meditated pathways of organ failure upon inflammation. Redox Biol. 13, 170–181, https://doi.org/10.1016/j.redox.2017.05.017 (2017).
doi: 10.1016/j.redox.2017.05.017 pubmed: 28578275 pmcid: 5458092
Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Sci. 275, 90–94 (1997).
doi: 10.1126/science.275.5296.90
Nishitoh, H. et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2, 389–395 (1998).
doi: 10.1016/S1097-2765(00)80283-X
Saitoh, M. et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596–2606, https://doi.org/10.1093/emboj/17.9.2596 (1998).
doi: 10.1093/emboj/17.9.2596 pubmed: 9564042 pmcid: 1170601
Hirata, Y. et al. TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1. Cell Rep. 21, 2447–2457, https://doi.org/10.1016/j.celrep.2017.11.007 (2017).
doi: 10.1016/j.celrep.2017.11.007 pubmed: 29186683
Nakajima, A. et al. Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Oncogene 27, 76–84, https://doi.org/10.1038/sj.onc.1210624 (2008).
doi: 10.1038/sj.onc.1210624 pubmed: 17599041
Schroyer, A. L., Stimes, N. W., Saab, W. F. A. & Chadee, D. N. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells. Oncogene 37, 1031–1040, https://doi.org/10.1038/onc.2017.396 (2018).
doi: 10.1038/onc.2017.396 pubmed: 29084209
Kim, H. S., Ullevig, S. L., Zamora, D., Lee, C. F. & Asmis, R. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. P Natl Acad. Sci. USA 109, E2803–E2812, https://doi.org/10.1073/pnas.1212596109 (2012).
doi: 10.1073/pnas.1212596109
Xu, C. et al. Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A. Neuropharmacol. 105, 270–284, https://doi.org/10.1016/j.neuropharm.2016.01.030 (2016).
doi: 10.1016/j.neuropharm.2016.01.030
Koh, E. M. et al. Ferulate, an Active Component of Wheat Germ, Ameliorates Oxidative Stress-Induced PTK/PTP Imbalance and PP2A Inactivation. Tox Res. 34, 333–341, https://doi.org/10.5487/Tr.2018.34.4.333 (2018).
doi: 10.5487/Tr.2018.34.4.333
Picco, V., Pages, G. & Linking, J. N. K. Activity to the DNA Damage Response. Genes. Cancer 4, 360–368, https://doi.org/10.1177/1947601913486347 (2013).
doi: 10.1177/1947601913486347 pubmed: 24349633 pmcid: 3863338
Fritz, G. & Henninger, C. Rho GTPases: Novel Players in the Regulation of the DNA Damage Response? Biomolecules 5, 2417–2434, https://doi.org/10.3390/biom5042417 (2015).
doi: 10.3390/biom5042417 pubmed: 26437439 pmcid: 4693241
Mercer, J., Mahmoudi, M. & Bennett, M. DNA damage, p53, apoptosis and vascular disease. Mutat. Res. 621, 75–86, https://doi.org/10.1016/j.mrfmmm.2007.02.011 (2007).
doi: 10.1016/j.mrfmmm.2007.02.011 pubmed: 17382357
Shah, N. R. & Mahmoudi, M. The role of DNA damage and repair in atherosclerosis: A review. J. Mol. Cell Cardiol. 86, 147–157, https://doi.org/10.1016/j.yjmcc.2015.07.005 (2015).
doi: 10.1016/j.yjmcc.2015.07.005 pubmed: 26211712
Madabhushi, R., Pan, L. & Tsai, L. H. DNA damage and its links to neurodegeneration. Neuron 83, 266–282, https://doi.org/10.1016/j.neuron.2014.06.034 (2014).
doi: 10.1016/j.neuron.2014.06.034 pubmed: 25033177 pmcid: 5564444
Amini, N. et al. Requirement of JNK1 for endothelial cell injury in atherogenesis. Atherosclerosis 235, 613–618, https://doi.org/10.1016/j.atherosclerosis.2014.05.950 (2014).
doi: 10.1016/j.atherosclerosis.2014.05.950 pubmed: 24956536 pmcid: 4104040
Kondo, K. et al. Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors. Mol. Nutr. Food Res. 59, 729–740, https://doi.org/10.1002/mnfr.201400537 (2015).
doi: 10.1002/mnfr.201400537 pubmed: 25546502
Paudel, I., Hernandez, S. M., Portalatin, G. M., Chambers, T. P. & Chambers, J. W. Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines. Biochem. J. 475, 3471–3492, https://doi.org/10.1042/BCJ20180603 (2018).
doi: 10.1042/BCJ20180603 pubmed: 30322886
Win, S., Than, T. A., Han, D., Petrovic, L. M. & Kaplowitz, N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J. Biol. Chem. 286, 35071–35078, https://doi.org/10.1074/jbc.M111.276089 (2011).
doi: 10.1074/jbc.M111.276089 pubmed: 21844199 pmcid: 3186406
Win, S., Than, T. A., Fernandez-Checa, J. C. & Kaplowitz, N. JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis. 5, e989, https://doi.org/10.1038/cddis.2013.522 (2014).
doi: 10.1038/cddis.2013.522 pubmed: 24407242 pmcid: 4040675
Chambers, J. W., Howard, S. & LoGrasso, P. V. Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo. J. Biol. Chem. 288, 1079–1087, https://doi.org/10.1074/jbc.M112.421354 (2013).
doi: 10.1074/jbc.M112.421354 pubmed: 23184940
Chambers, J. W., Pachori, A., Howard, S., Iqbal, S. & LoGrasso, P. V. Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. J. Biol. Chem. 288, 4000–4011, https://doi.org/10.1074/jbc.M112.406777 (2013).
doi: 10.1074/jbc.M112.406777 pubmed: 23258542
Chambers, T. P., Santiesteban, L., Gomez, D. & Chambers, J. W. Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity. Toxicol. 382, 24–35, https://doi.org/10.1016/j.tox.2017.03.006 (2017).
doi: 10.1016/j.tox.2017.03.006
Vallerie, S. N. & Hotamisligil, G. S. The role of JNK proteins in metabolism. Sci. Transl. Med. 2, 60rv65, https://doi.org/10.1126/scitranslmed.3001007 (2010).
doi: 10.1126/scitranslmed.3001007
Mehan, S., Meena, H., Sharma, D. & Sankhla, R. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci. 43, 376–390, https://doi.org/10.1007/s12031-010-9454-6 (2011).
doi: 10.1007/s12031-010-9454-6 pubmed: 20878262
Pal, M., Febbraio, M. A. & Lancaster, G. I. The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. J. Physiol. 594, 267–279, https://doi.org/10.1113/JP271457 (2016).
doi: 10.1113/JP271457 pubmed: 26608096
Chambers, J. W., Cherry, L., Laughlin, J. D., Figuera-Losada, M. & Lograsso, P. V. Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1). ACS Chem. Biol. 6, 808–818, https://doi.org/10.1021/cb200062a (2011).
doi: 10.1021/cb200062a pubmed: 21563797 pmcid: 3158843
Win, S., Than, T. A. & Kaplowitz, N. The Regulation of JNK Signaling Pathways in Cell Death through the Interplay with Mitochondrial SAB and Upstream Post-Translational Effects. Int J Mol Sci 19, https://doi.org/10.3390/ijms19113657 (2018).
doi: 10.3390/ijms19113657
Cousin, S. P. et al. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinol. 142, 229–240, https://doi.org/10.1210/endo.142.1.7863 (2001).
doi: 10.1210/endo.142.1.7863
Noguchi, T. et al. Nuclear-accumulated SQSTM1/p62-based ALIS act as microdomains sensing cellular stresses and triggering oxidative stress-induced parthanatos. Cell Death Dis. 9, 1193, https://doi.org/10.1038/s41419-018-1245-y (2018).
doi: 10.1038/s41419-018-1245-y pubmed: 30546061 pmcid: 6294141
Mali, P. et al. RNA-guided human genome engineering via Cas9. Sci. 339, 823–826, https://doi.org/10.1126/science.1232033 (2013).
doi: 10.1126/science.1232033
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Sci. 339, 819–823, https://doi.org/10.1126/science.1231143 (2013).
doi: 10.1126/science.1231143
Naito, Y., Hino, K., Bono, H. & Ui-Tei, K. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinforma. 31, 1120–1123, https://doi.org/10.1093/bioinformatics/btu743 (2015).
doi: 10.1093/bioinformatics/btu743
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784, https://doi.org/10.1038/nmeth.3047 (2014).
doi: 10.1038/nmeth.3047 pubmed: 25075903 pmcid: 25075903
Brenner, S. The genetics of Caenorhabditis elegans. Genet. 77, 71–94 (1974).
Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G. & Ahringer, J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2, RESEARCH0002, https://doi.org/10.1186/gb-2000-2-1-research0002 (2001).
doi: 10.1186/gb-2000-2-1-research0002 pubmed: 11178279
Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nat. 421, 231–237, https://doi.org/10.1038/nature01278 (2003).
doi: 10.1038/nature01278
Rual, J. F. et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res. 14, 2162–2168, https://doi.org/10.1101/gr.2505604 (2004).
doi: 10.1101/gr.2505604 pubmed: 15489339 pmcid: 528933

Auteurs

Yusuke Hirata (Y)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Aya Inoue (A)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Saki Suzuki (S)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Miki Takahashi (M)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Ryosuke Matsui (R)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Nozomu Kono (N)

Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Takuya Noguchi (T)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Atsushi Matsuzawa (A)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. atsushi.matsuzawa.c6@tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH